S
AUPH icon

SignatureFD’s Aurinia Pharmaceuticals AUPH Stock Holding History

SignatureFD’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.62K Buy
+390
New +$6.23K ﹤0.01% 2780
2025
Q4 		– Sell
-179
Closed -$1.98K – 3418
2025
Q3 		$1.98K Hold
179
– – ﹤0.01% 2955
2025
Q2 		$1.52K Sell
179
-111
-38% -$890 ﹤0.01% 2936
2025
Q1 		$2.33K Buy
290
+43
+17% +$348 ﹤0.01% 2833
2024
Q4 		$2.22K Buy
247
+68
+38% +$555 ﹤0.01% 2841
2024
Q3 		$1.31K Hold
179
– – ﹤0.01% 2942
2024
Q2 		$1.02K Buy
+179
New +$943 ﹤0.01% 2897
2023
Q1 		– Sell
-52
Closed -$225 – 3283
2022
Q4 		$225 Buy
52
+21
+68% +$122 ﹤0.01% 3181
2022
Q3 		$0 Buy
+31
New +$268 ﹤0.01% 3107
2022
Q1 		– Sell
-140
Closed -$3K – 3136
2021
Q4 		$3K Buy
+140
New +$3.32K ﹤0.01% 2551

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SignatureFD's AUPH Position: Q2 2026 in Review

SignatureFD opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 390 shares worth $6.62K. The stake represents ﹤0.01% of the portfolio and ranks #2780 among its holdings. This is a return to the name: SignatureFD previously reported a position in AUPH as recently as Q3 2025.

SignatureFD first reported a position in AUPH in Q4 2021 and has held it in 10 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • SignatureFD held 390 shares of Aurinia Pharmaceuticals worth $6.62K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new SignatureFD position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2780 holding.
  • SignatureFD first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.